← Back to Search

Other

Essential oils for Nausea and Vomiting

Phase 2

Waitlist Available

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (12 months prior to intervention) and during intervention (12 months during study)

Awards & highlights

Study Summary

This trial is testing whether inhaled aromatherapy can help reduce symptoms of nausea and anxiety in stem cell transplant patients.

Eligible Conditions

Nausea and Vomiting
Anxiety

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (12 months prior to intervention) and during intervention (12 months during study)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (12 months prior to intervention) and during intervention (12 months during study)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (12 months prior to intervention) and during intervention (12 months during study) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in anxiety symptoms

Change in chemotherapy-induced nausea, vomiting and retching symptoms

Secondary outcome measures

Antiemetic administration

Inpatient falls

Patient satisfaction

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: Intervention - nausea/vomitingExperimental Treatment1 Intervention

Patients indicating that nausea/vomiting is their primary symptom of concern and are randomized to receive intervention will be allocated to the intervention - nausea/vomiting arm. This arm will receive peppermint inhaled aromatherapy patches (or mandarin as an alternative if they have a peppermint sensitivity).

Group II: Intervention - anxietyExperimental Treatment1 Intervention

Patients indicating that anxiety is their primary symptom of concern and are randomized to receive intervention will be allocated to the intervention - anxiety arm. This arm will receive lavender inhaled aromatherapy patches.

Group III: Control - nausea/vomitingPlacebo Group1 Intervention

Patients indicating that nausea/vomiting is their primary symptom of concern and are randomized to receive control will be allocated to the control - nausea/vomiting arm. This arm will receive blank (no essential oil infusion) aromatherapy patches.

Group IV: Control - anxietyPlacebo Group1 Intervention

Patients indicating that anxiety is their primary symptom of concern and are randomized to receive control will be allocated to the control - anxiety arm. This arm will receive blank (no essential oil infusion) aromatherapy patches.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Essential oils

2020

Completed Phase 4

~410

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor

980 Previous Clinical Trials

982,889 Total Patients Enrolled

Indiana University HealthOTHER

30 Previous Clinical Trials

15,940 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current limit for participants in this medical experiment?

"Affirmative. According to clinicaltrials.gov, this study is actively searching for participants and was first advertised on March 7th 2022 before undergoing a recent edit on August 22nd 2021. The medical trial seeks 100 volunteers at one site of recruitment."

Answered by AI

What potential risks are posed by the use of Essential oils?

"The safety profile of essential oils has been judged to be a 2 out of 3, as this is only in the second stage of clinical trials. There have been findings that indicate its safety, but none yet which speaks to efficacy."

Answered by AI

Is the recruitment period for this experiment limited to any age group in particular?

"Those hoping to participate in this trial must be within the age range of 18 and 100 years, inclusive."

Answered by AI

What criteria must potential participants meet for inclusion in this trial?

"This clinical trial seeks to enrol 100 patients aged 18-100 suffering from anxiety. To be eligible, they must demonstrate alertness and the ability to interact with researchers as well as read and write in English. Additionally, they must have received either autologous or allogeneic bone marrow transplants at an adult academic health centre situated in the Midwest region of America."

Answered by AI

Is the recruitment process for this clinical trial still open?

"According to clinicaltrials.gov, this research trial is currently recruiting individuals for participation. It was first posted on March 7th 2022 and the most recent edit took place August 22nd of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of Aromatherapy to Reduce Symptom Burden

Monica Bates 2022. "Use of Aromatherapy to Reduce Symptom Burden". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05251337.